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Abstract
Blood group serological medical devices produced in Hunga-
ry are in the focus of this paper. The first Automatic Coombs Test 
Analyzer (ACT) was constructed approximately 20 years ago. 
There is a huge competition between the blood group serologi-
cal devices applying different types of techniques (e.g. micro-
plate, card or spin tube technique) which can carry out all the 
applied methods (e.g. direct agglutination, enzyme, antiglobulin 
or Coombs, or Polybrene method). Therefore, the continuous 
development of such an instrument is inevitable. Involving users 
can result in ideas that may have serious impact on the product 
development process. Within the confines of our research five fo-
cus groups including thirty-five participants from three Hungar-
ian laboratories were conducted in order to gain user opinions 
and expectations regarding the Advanced ACT. As a result the 
optimal ratio between automation and being able to control the 
results manually was pointed out to be a crucial factor of the 
users. A possible solution was shown to eliminate or at least 
decrease the potential stress mentioned by them.
Keywords
Product development · Innovation · Automation · Focus 
group · Blood group serology
1 Introduction
In the field of blood group serology a huge amount of meas-
urements are performed under different working conditions and 
according to diverse subjective laboratory routines. The daily 
number of samples, their arrival to the laboratory, the time-
frame a laboratory has for processing them, the number of em-
ployees and their qualification raise quite different needs that 
can only be satisfied with a wide range of laboratory devices.
Seven multinational companies offer blood group serologi-
cal devices in the international market. All of these have their 
own closed system (differing from the conventional serology) 
that includes disposables.
Closed systems dominate the market, but the spin tube tech-
nique is also needed on the one hand due to professional reasons 
(since it is considered to be the so-called ‘golden standard’), 
and on the other hand due to its remarkable cost-effectiveness.
The spin tube technique (which is an open system) served 
as a base for the elaboration of the whole field of blood group 
serology at the end of the last century. It has been automated 
in Hungary by only one company. The device produced by 
them is called ACT (which stands for Automatic Coombs Test 
Analyzer). Its competitors elaborated novel serological circum-
stances for their disposable tools, which contributed to the high 
costs of the tests done by them.
The article is based on the ACT product line which uniquely 
helped to spread the cost-effective tube technique of the field of 
immune hematology by means of automating it. The continu-
ous developments of the ACT automatic instruments provide a 
remarkable cost-effectiveness (regarding the price of the device 
and the tests) together with the same quality of measurements.
The measuring method for blood group serological tests, 
based on photosedimentory, has been worked out uniquely by 
the company mentioned above. They elaborated and spread the 
agglutination analyzer called ACT-24 widely in the Hungarian 
transfusion diagnostics.
Through the years trends have shown the increasing need 
for automated instruments in contrast to the earlier manual 
blood group serological measurements. Faster and more au-
tomated devices were and are demanded both nationally and 
internationally.
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Beyond the faster sample process another advantage of the 
automated instruments is that they can carry out the steps of the 
analysis (e.g. pipetting, incubating, centrifuging, reading etc.) 
in such a precise way that they lead to far fewer doubtful results 
which need to be overwritten by the users. As a consequence 
the responsibility of the user is smaller and fewer repeated 
measurements (thus e.g. fewer test cells) are needed.
A new blood group serological instrument was invented as 
a response to the demand for the automation of the tube tech-
nique. The main point was to keep all the benefits of the tube 
technique and at the same time to eliminate the false results 
caused by human error by means of reaching a higher level of 
automation.
Automation and the opportunity of checking the results man-
ually are core questions in case of modern serological devices 
with tube technology. One of the reasons is to be able to detect 
human error, and the other is that the users should also be able 
to detect the possible technical errors of the device. The key 
issue is to have the control over the secure operation of the in-
strument, meaning to have the opportunity to choose between 
operating automatically and manually, since an error (commit-
ted either by the user or the device) may lead to a threat to life.
1.1  Advantages of the conventional
spin tube technique
1. All the scientific background of modern blood group serol-
ogy was developed by means of the spin tube technology.
2. All the known antibodies were discovered by means of the 
spin tube technology. (There is not one antibody-antigen 
system that was discovered by means of gel cards.)
3. Only by means of the spin tube technology can all the 
known methods (Coombs, enzyme, PEG and Polybrene) 
be performed.
4. The spin tube technology combined with sedimentation 
analysis can analyze the size of the particles in the easiest 
way; no foreign phases are used.
5. It can be used together with reagents from different sourc-
es: the uncertainties can be limited by taking advantage of 
the different biological background of the reagents.
6. The patient’s and the donor’s samples are used in their 
natural liquid state; there is no need for bounding them to 
solid phase.
7. Presently it is the cheapest known technique.
8. The professionally performed tube technique is consid-
ered to be the ‘golden standard’ up to this time.
1.2  Disadvantages of the conventional
spin tube technique
1. The proper manual use of the tube technique can be learnt 
with some difficulty. Subjective sources of errors can be: 
reading the results and gently shaking the tubes manu-
ally. (These risks can be eliminated by automating the 
measurement which has already been carried out in case of 
the ACT product line.)
2. The perfect cell washing should be carried out in case of 
each measurement by means of proper devices of high 
quality. (In case of gel cards the possibility that cell wash-
ing errors occur can be prevented by high quality produc-
tion technology. The Advanced ACT Robot (see below) is 
a solution for this problem.)
The reason for the continuous improvement of the ACT 
product line is that according to most experts the liquid phase 
sedimentation analysis is the most suitable technique for de-
tecting agglutinates, for measuring in a semi-quantitative way, 
and for detecting hemolysis as a side phenomenon.
Techniques applied among the competitors of the ACT prod-
uct line are based on similar principles, but using a different 
medium (e.g. gel column) has more disadvantages relating to 
reading the results: they are slower and more expensive. How-
ever, their additional advantage is that cell washing in their 
case does not require huge instrumental work, ‘only’ the proper 
quality insurance of the production of the gel cards.
This competitive disadvantage had to be eliminated by the 
small-sized company producing the ACT product line by means 
of improving the cell washing to make it absolutely reliable. 
In case of the improvements mentioned before the competitive 
advantage of the easy measuring (namely all of the blood group 
serological measurements can be performed according to the 
highest quality standards in the same way by means of ACT 
automats) could be used.
2 Product development and innovation
‘Innovate or die!’
Innovation is a competitive advantage that means an inten-
tional process of new products that satisfies or generates new 
needs (Lógó, Süle [4]). Innovation is a new combination of 
production factors (Schumpeter [7]). In our case (innovation 
of a new blood serological device) the type of innovation was 
the development of a new product, in the physical scene too. As 
Schumpeter [7] states, a basic feature of innovation is the eco-
nomical applicability, thus a new product is not an innovation 
unless it is economically applicable. As a result of this feature 
financial and marketing aspects should also be included in the 
product development process.
Product engineering and product development means the 
process from an idea to the materialization of a new product. 
Product development is a broader concept that covers the pro-
cess from the seeking for a new idea as far as the introduction 
of the new product to the market. Finally product innovation 
also covers a wider perspective from the company’s strategic 
decision through the product development to the research of 
user experience and feedback of these to the company (Lógó, 
Süle [4]). In this sense I would like to introduce the new blood 
group serological device (called Advanced ACT) in the frame 
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of product innovation. This article covers the research of user 
experience, and the conclusions of this process.
The development of the new device is a strategic process that 
should include the analysis of the company’s current position 
in the market (both strong and weak points and competitors) 
and also the analysis of the inner structure of the company and 
the expected changes, tendencies of the product and its users 
(Lógó, Süle [4]). These factors are combined in the product 
strategy which describes the values and function that the new 
product should incorporate. A function of a product is not a sin-
gle construction but it is a complex combination of technical, 
economical and also psychological factors (see Table 1).
It is important to take into consideration that the previously 
collected product functions are not equally important for the 
users and for the company. As a result a product could be de-
scribed as an onion built up from layers on each other (Kotler 
[3]). In the center of this concentric system the product core can 
be found that holds the basic utility of the product. The product 
core is what the product is for: the satisfactory solution of the 
basic need. Further in the other layers there are products expect-
ed or extended or potential products that are based on consumer 
expectations, brands, consumer service experience and price.
From the perspective of marketing the following ques-
tions must be answered in case of a product: (1) Whom does 
the product serve?, (2) What can the product be used for?, (3) 
What are the features of the product?, (4) What is the reason 
to buy this specific product?, (5) What does the product mean 
for the customers? A product concept in the strategic meaning 
should include all these questions mentioned (Rekettye [6]). 
The task description includes the functional and technical in-
formation that must be included in product development for a 
specific purpose.
In the product innovation process, as mentioned above, the 
feedback gained from the users and customers are essential 
to be included. Before the introduction to the market a pro-
totype of the product should be tested by involving recruited 
potential (expected) users. The experience from the presenta-
tion and testing of the product can serve as important feedback 
for further corrections of the products, to reach the satisfaction 
of both the users and the company.
One of the key aspects of product development and innova-
tion is ergonomics and the ergonomic quality of the product 
(Antalovits [1]). The user-focused product development empha-
sizes the ergonomic features because this means a design for 
human use. In this process the users should be included in the 
development already in the planning phase: their expectations, 
physical parameters, knowledge, needs, task work features and 
security reasons. In the testing of the product prototype the 
user experience, the feedback of usability testing and opinions 
are key features for the development process. In the market-
ing phase the information gained from users about the product 
should serve as main messages emphasizing the strength of the 
innovated product. From the perspective of ergonomics a well-
designed product (among others) should keep the error rate low, 
help to prevent user errors, let the user correct the committed 
errors easily and take the users’ actual skills and capabilities into 
account (Antalovits [1]). The three key features are (1) safety, 
(2) efficiency and (3) comfort of usage (Antalovits [1]). The 
order of mentioning these features reflects their priority rank. 
Safety is the possibility of operating the product (in our case for 
a blood serological device) without errors which could threaten 
certain persons’ (in our case patients’) health. Efficiency means 
that the users can use the product with little physical or mental 
effort and without errors. This is strictly connected to the fit of 
the device into the users’ physical, mental, and psychological 
parameters and also to the work processes. Finally the comfort 
of the product means the positive emotions towards it including 
the esthetics and social attraction.
From the point of view of safety it is important to consider 
what kind of errors can happen, what the possible consequenc-
es of these errors are, and what the probability of these errors 
is (Geri, Süle [2]).
3  Blood group serology –
methods, techniques, history
To be able to have a closer look at the market of blood group 
serology, first of all the methods and techniques used in labora-
tories should be mentioned.
3.1 Methods
Methods are the circumstances of reactions determined 
chemically and/or biologically which help the antibodies and 
antigens bound. These methods were elaborated during the last 
century as part of the scientific principles of blood group serol-
ogy in order to be able to discover all the important antigen-
antibody systems.
All of those methods together with their opportunities and 
limits were elaborated before 1960. It can be stated that there 
Technical function How it works
Psychological function
Product experience, emotions connected 
to the product
Sociological functions Social meaning of owning this product
Economical function
Economical acceptability, mainly the 
price of the product
Documentation function
A product from the past describes the era 
when it was used
Environmental function Products’ relation to nature
Tab. 1. Product functions (Lógó, Süle [4])
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has not been any competition in the field of applied methods 
for decades.
But there is a serious competition between the blood group 
serological techniques which can carry out the mentioned 
methods.
A specific method can indicate only a definite group of an-
tigen-antibody systems. There is not one single method that 
could be used for all the antigen-antibody systems, so it can be 
stated that more methods should be used parallel for an overall 
measurement. In contrast to this there are several techniques 
which can carry out all the methods.
The most well-known methods are the following:
• Direct agglutination method
• Enzyme method
• Antiglobulin or Coombs method
• Polybrene method
3.2 Techniques
Grouping by chronology 
• Earlier techniques
 – Slide technique (it can be used for direct agglutination 
method)
 – Spin tube technique (it can be used for all the meth-
ods mentioned above, it is universal and is called the 
‘golden standard’)
• Modern techniques
 – Sedimentation techniques (e.g. ACT-24, DiaMed, 
ScanGel, Grifols etc.)
 – Immobilization techniques (bounding to solid surface 
instead of agglutination)
Grouping by appearance
• Automatic tube technique (ACT-24: it can be used for all 
the methods mentioned above, it is universal and repre-
sents the ‘golden standard’ as mentioned above)
• Microplate technique (it can be used for all the meth-
ods mentioned above by means of using magnetized red 
blood cells or immobilized reagents on the wall of the 
microwells)
• Column technique (it can be used for all the methods 
mentioned above)
3.3 History
The date of the discovery of different blood groups and the 
names of the methods and techniques can be seen in the fol-
lowing picture.
First solutions to avoid subjective errors can be seen in the 
following picture.
The first automats can be seen in the following picture.
Fig. 1. Development of blood group serology
Fig. 2. First solutions to avoid subjective errors
Fig.3. First automats
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4 ACT product line
The first blood group serological instrument made by the 
only Hungarian company that offers automats for measure-
ments in the field mentioned was the so-called ACT-24. It com-
bines the conventional spin tube technique, which is the gen-
erally accepted reference method for antibody screening, with 
a degree of automation. While the sample preparation is still 
being done manually, the AHG-dispensing, washing, diluting, 
centrifuging, as well as the reading, displaying, printing and 
archiving of the results is computer controlled, thus providing 
a standardized processing procedure.
After the first series of ACT-24 semiautomats the company 
launched a continuous development. First they developed the 
first model of ACT Robot. The ACT Robot is a fully automated 
system which uses the “golden standard” spin tube technique. 
Its main advantage is that it can carry out any kind of tube test. 
It adapts to the needs of the customers by making it possible to 
program any variation of methods and applications. The instru-
ment is an open system; the reagents of any company can be 
used in it. It works with disposable plastic cuvettes, which has 
to be replaced after every run (Cytotech Ltd.).
At the end of the year 2012 a new situation occurred due 
to the fact that the construction of the fully automated, “walk 
away” system the Advanced ACT Robot was finished.
The company also had to compare the disadvantage of the 
delay due to the production of the Advanced ACT to the ben-
efits of the “walk away” construction in order to decide which 
model should step into the world market first (the ACT Robot 
or the Advanced ACT).
The differences of the advanced and previous model are de-
tailed below.
4.1  Technical comparison of the existing
and the advanced models
Descriptions and facts can be read first and remarks follow 
in italic.
The existing model (ACT Robot) is in continuous routine use 
in different cities in Hungary. The prototype of the Advanced 
ACT has been built.
Since 2008 the company has had the opportunity to involve 
user needs in the product development process since they had 
won a tender and from this they could cover the expenses of 
different user-focused researches.
In 2008 and 2010 several focus group analyses were con-
ducted (partly by the author), however here this paper concen-
trates on the ones conducted (again partly by the author) in 
2012. The main reason to do so is that the Advanced ACT was 
tested among users only in the frame of these latter focus group 
sessions.
5 Empirical research
5.1 The goal of the study
The goal of this study is to present the main results of this 
user-focused product development process of the Advanced 
ACT model. I am going to focus on how in this process the 
innovation included the users’ opinions and expectations and 
in what particular ways the latest version of the ACT device 
could provide the users with relevant answers to their former 
expectations.
5.2 The focus group method
The focus group is a popular qualitative research tech-
nique in social sciences as a special form of group interview 
(Szokolszky [8]). At the same time it is also a widely used re-
search technique of the field of user-centered product develop-
ment. Usually the groups consist of 6-12 carefully recruited 
participants. The members of the group discuss a specific subject 
(in our case the ACT Robot and the Advanced ACT blood group 
serological devices). The discussion is moderated by the group 
leader (called ‘moderator’).
In the group discussion the participants share their opinions, 
emotions, and experience about the presented devices. The 
group discussion as a social setting facilitating the openness, the 
smooth communication and the spontaneity of the participants. 
These advantages justified the selection of the focus group 
technique in this research presented. This group interview tech-
nique usually produces more information as results than that a 
classical, one-to-one interview may produce. The qualitative 
analysis of focus group discussions serve as a basis for the fur-
ther development and marketing of the Advanced ACT device.
The leader of the focus group has to control and focus the 
flow of the group discussion. The moderator makes sure that 
all members can share their opinion and none of the members 
dominates the group discussion counterproductively. In this 
way the moderator’s role is to facilitate the interactions and 
opinion sharing among participants. The moderator as a leader 
has to communicate the group’s frame of working the operat-
ing rules and the goals. A focus group is a proper and unbiased 
tool for data collection concerning the opinions related (in our 
case) to the mentioned blood group serological devices when it 
is conducted with defined goals including the important topics 
and when the atmosphere is open for communication.
The selection of the focus group participants is based on their 
common interest and experiences in general. In our case we 
have selected the users and potential users of the tested devices 
to participate in the focus groups. This paper presents only the 
results from those groups where the participants actually use 
an ACT Robot in their daily practice. This selection strategy 
allows the collection of real user experience.
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Tab. 2. Technical comparison of the existing and the advanced models
Features ACT Robot Advanced ACT
Software Difficult to modify, extended tests are necessary 
even after minor changes. Not flexible. 
Flexible module software system based
on industrial robot controller algorithm. 
Serological performance Highest quality of reading
Results given by this model are 
equal to the new system
Hemolysis: checking visually 
Highest quality of reading
There are no changes in the evaluation principle, but 
the appearance of the doubtful results is minimized.
Hemolysis: automatic checking
Construction (general) The reactions are prepared directly 
into the cuvettes of the ACT rotor.
Centrifuge rotors with contaminated cuvettes are 
replaced manually for cleaning.
The ACT units are occupied for the time of 
dispensing and incubation as well.
2pcs of ACT units are necessary
Separate dispensing discs are available
for dispensing and incubation.
The built in centrifuge rotor is loaded with the 
(incubated) samples automatically from the 
dispensing discs.
The cuvettes are cleaned automatically between cycles.
ACT units can continuously work, consequently a new 
system with a single ACT unit can be 1.5 times more 
effective than the previous one (with double ACT).
Decanting system construction Decanting probes with lifting mechanisms
and with multi channel vacuum pumps.
Mechanically sensitive, higher risk of reliability.
Relatively slow.
One drop of residue unavoidable: appropriate for 
cell washing, but not really for cleaning cuvettes. 
Advanced construction for centrifugal decanting.
More robust mechanism.
Quick.
Possible to dry the cuvettes by centrifugal force.
Incubation In ACT units In inner incubator
Number of ACT units 2 pieces
Not possible to double
1 piece
Possible to double
Number of rotors Min. 4 replaceable 1 fixed piece 
Changing cuvettes: Options:
– replacing one by one:
       – disposable or
       – washing
– washing the whole rotor in a special machine.
There are concepts for developing a washing 
machine, but none for a quick dryer.
Fixed cuvettes with automatic washing and drying
 
Disposables Cuvettes EUR 70/1000 tests No disposables
Velocity (AGT/8hours) 580 940
Walk away User must change rotors after every 36 tests.
Optimally a pair of rotors can be replaced at the 
same time. One hour walk away time in the case 
of AGT
Up to 8 times longer walk away time.
 
Dimensions (mm) 1000x500x500 700x600x500w
 
Weight (kg) 50 60
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5.3 Participants
The participants of the focus groups presented in this study 
are users of the ACT Robot blood group serological device. 
The five focus groups conducted included thirty-five partici-
pants from three laboratories (from Kecskemét and Budapest) 
using the ACT Robot device. Six participants are physicians 
specialized in blood group serology; there were three executive 
assistants, and twenty-six assistants from the laboratories.
The group size varied from six to eight people depending on 
the availability of the participants. The participants were mixed 
from different laboratories in order to facilitate the discussion 
and sharing of experience across institutes.
A group session took in average 2 or 2.5 hours, which was 
video recorded and noted. The scenario of the focus group start-
ed with the introduction of the participants and the presentation 
and acceptation of the group roles. Then it went on to the col-
lection of experience about the ACT Robot blood group sero-
logical device. The opinions and experience mentioned in the 
group discussion were noted on flipchart by the group leader 
and then assumed by the participants when they summed up the 
conclusions. The next part of the group session was the presen-
tation of the prototype of a new ACT blood group serological 
device (the so-called Advanced ACT) in physical reality includ-
ing technical data specifications and an interactive demonstra-
tion of its work process. The participants had the opportunity 
to watch a whole 40-minute-long measurement process of the 
device and also questions could be asked. After this session the 
group settled to collect the opinions about the new ACT device 
presented previously, especially focusing on expectations.
5.4 The room and place of the focus group
As a part of the product innovation process the targets of 
the conducted focus groups were the experts using ACT Robot 
devices and among them the expected users of the Advanced 
ACT blood group serological device. In order to avoid biased 
opinions the focus groups were conducted in a meeting room 
of an independent company producing serological accessories 
(Reagens Ltd. Budapest) instead of the office of the developer 
company (Cytotech Ltd). The room of the focus groups was 
isolated and calm enough to provide an open atmosphere for 
opinion sharing. The participants sat down around a table in 
the middle of the room. They received pen and paper to take 
notes and the leader of the group used a flipchart to collect the 
opinions in a structured way visible for all. In the room there 
was one ACT Robot and one Advanced ACT device placed. 
Both were possible to be inspected and this way they served 
for elicitation of experience and ideas in the group sessions. 
The physical setting of the groups is presented in the following 
figures.
Focus group participants during a discussion can be seen in 
this picture. The group moderator was summarizing the opin-
ions on the flipchart.
Fig. 4. Physical setting of the groups
Fig. 5. Layout of the focus group room
Fig. 6. The Advanced ACT device (from outside) Fig. 7. The Advanced ACT device (from inside)
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6 Results
Of the results only the product development process related 
data are presented here. The recorded videos and flipchart notes 
are analyzed qualitatively. In this section I am going to focus 
on the questions raised about the ACT Robot (from user ex-
perience) and I am going to compare them with the possible 
answers found in the presentation of the Advanced ACT device. 
With this structure the study aims to show the key points of the 
product development process which reflect to user opinions and 
needs. But this reaction to user needs can also be exaggerated 
which leads to focusing on one problem while other problems 
develop as a side effect. The main purpose here in this study is 
to show that the permanent application of the product develop-
ment goals and strategy would help to keep the balance among 
the different user opinions.
To be able to see why the devices mentioned below are com-
pared with each other it has to be emphasized that the develop-
ment of the new Advanced ACT device was mainly motivated 
by the automation of the manual work processes in case of the 
ACT Robot (see Tóvölgyi, Hámornik, 2013).
6.1 Questions and answers
Table 3. presents the questions raised by the ACT Robot de-
vice and previous ACT devices paired with the answers pro-
vided by the new ACT device as a result of the product devel-
opment process.
6.2 Opinions about automation
Automation appeared to be a two-folded concept in this sec-
tion (see Tóvölgyi, Hámornik, 2013). On the one hand, the au-
tomation of the blood group serological measurement process 
helps to save time and effort for the users. However, on the 
other hand, the automation as a process running freely with 
no need for human action led to the feeling of lack of control 
over the measurement process. Lack of control is first of all a 
question of safety: is the automated process reliable enough. 
Secondly automation is a question of competences and the 
users’ feeling of usefulness including all levels of the laborato-
ry staff. The participants mentioned that the automation of the 
Advanced ACT device saves time for them (‘the machine does 
the cleaning of cuvettes; it can be loaded continuously, etc.’). 
But the very same participants mentioned that this automated 
process is closed for manual validation, correction, inspection 
(‘the results cannot be controlled manually, the process can-
not be interrupted, thus the questionable results remain uncer-
tain’), even though the user (physician or assistant) is respon-
sible for the result of the measurement (as a medical decision).
This leads to a new question that is to be analyzed more thor-
oughly: is there a substantive difference between the two ten-
dencies? The manual spin technique used to be the only tech-
nique carried out manually and checked visually. For those, 
who are professional considering this technique, it has always 
been the most efficient and widely used technique. All the auto-
mated systems decrease the feeling of being able to control the 
processes, but at the same time it means to simplify the laborato-
ry routines. And in the daily laboratory routine it is expected by 
the users that a device can carry out the whole process by itself. 
There are only a few physicians or assistants who really are in-
terested in having a closer look at the results with their own eyes.
This could lead to a new and interesting study where phe-
nomena, such as indirect sensation (e.g. not trusting the rear-
view mirror while reversing the car and because of that turning 
one’s head backwards), could be analyzed.
7 Conclusion
The results presented here show a heterogeneous picture of 
user opinions. The need for automation is satisfied during the 
steps of the innovation process, but at the same time a new kind 
of dissatisfaction feeling has come up. On the one hand, due 
to the full automation the users are not provided the opportu-
nity to control the measurement which in some cases can cause 
dissatisfaction and new user questions. On the other hand, the 
development process answered several questions gained from 
earlier user opinions that facilitate safety, utility, and comfort 
which have led to a higher level of usability and satisfaction.
In order to avoid or at least decrease the stress caused by not 
being able to control the results manually, the video camera 
integrated in the Advanced ACT device had to be upgraded, so 
that it can record the reactions in the cuvettes and can capture 
the bottom of the cuvettes, too. Due to some innovative devel-
opment the new camera is capable of doing so. By means of 
these videos the users can have an almost realistic picture of 
the results, thus not being able to take the cuvettes out of the 
machine due to its closed structure may be less stressful for 
them. These short videos are kept by the computer connected 
to the Advanced ACT device, so that they can be checked over 
and over again any time by the users.
The innovation process and the product development pro-
cess of Cytotech Ltd. should be strategic in the future as well 
Fig. 8. The software interface of the Advanced ACT device
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Tab. 3. Questions raised by the ACT Robot device and previous ACT devices and answers provided by the new ACT device
Features
Problems and questions related to  
the ACT Robot and previous ACT devices
Answers provided by the 
Advanced ACT device
Cuvettes The disposable plastic cuvettes are generating 
permanent costs and environmental load.
The plastic cuvettes are replaced by reusable glass cuvettes.
The variations in the thickness of the walls of the 
plastic cuvettes lead to ambiguous results 
(the variations are caused by the manufacturing of 
the cuvettes’), causing ambiguous sedimentation 
curves.
The quality of the glass cuvettes is better, and the walls of 
them are homogenous, thus no ambiguity is caused.
The manual cleaning of cuvettes is not reliable. The automated device cleans the glass cuvettes, and the 
testing results show that this cleaning process is effective 
enough.
Quantity of (blood) 
samples processed a day
The ACT units are not operating during the 
preparation and incubation phases and this limits 
the quantity of blood samples processed a day.
Except for the first running of the day the device operates 
continuously:  there are samples in both the rotor and the 
incubation area. The full automation keeps the device in non-
stop operation when it is continuously loaded with samples.
The holder clips of the 
reagent substances
Due to the permanent removing and exchange of 
the reagent substances, the plastic holder clips 
were frequently broken.
The new holder clips are made of more flexible material in 
order to prevent breakage.
Sedimentation curves The users rarely base the results on sedimentation 
curves; they even prefer not to learn the 
interpretation of these curves.
The incubation and the examination processes are now 
separated physically thus the curves are more reliable and 
more applicable.
Incubation sometimes distorts the curves.
Video camera The picture taking process is slow. A new camera device is built in which is faster and more 
reliable.Sometimes the camera takes low quality or even 
unusable pictures.
Due to the position of the camera the reactions at 
the bottom of the cuvettes were sometimes invisible 
to the camera since the bottom of the cuvettes 
could not be captured by the camera.
The new camera captures the bottom of the cuvettes, too.
The shaking of screening 
and test cells
The manual shaking of the screening and test cell 
bottles is time-consuming and demands human 
labor capacity. The skipping of the shaking process 
may lead to ambiguous results in which case the 
test must be repeated.
The fully-automated device shakes up the cells before every 
test.
Questionable results The automated measurement stops when it finds 
a questionable result, and it does not go on unless 
the user manually validates it.
The fully-automated device continuously processes the 
blood samples and stores the questionable results for further 
validation. It does not stop for validation, so it can be done at 
any time without interrupting the measurement process.
The size of the device The size of the ACT Robot is relatively extensive 
compared to the crowded laboratory conditions in 
Hungary. (1000x500x500mm)
The new ACT device is smaller (700x600x500mm) which 
provides a better fit in the laboratory settings in the market.
Design The users of the ACT Robot are not content with 
the esthetic features of the device.
The user opinions (e.g. doors, and opening mechanisms) 
were taken into consideration when creating the design of the 
new ACT device.
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(like it was in the last 5 years) in order to keep its focus on and 
mutual feedback with the actual and potential users.
The producer of the ACT product line has been able to carry 
out the following: ‘innovate systematically or die’ – our open-
ing sentence modified. In their case innovation has been an es-
sential tool in being able to survive the economic crisis over 
the last years. Continuous improvement has become one of 
the main corporate competences. As a possible consequence 
of this attitude the company has recently signed a memoran-
dum of understanding [11] about new projects with the Kuwait 
Life Sciences Company, which is fully owned by the National 
Technology Enterprises Company (NTEC); a Kuwait Invest-
ment Authority (KIA) fully owned company [12] (Hungarian 
Government). This user-centered product development process 
may serve as an example for other companies.
